Avid Bioservices Inc (CDMO)

[masshysteria]

tarvacin - the examples you pasted just help drive the conclusion that Astra-peregrine agreement is not following any of the previous models and details remain to be seen.

Astra's PRs have been very clear on the four previous deals.

The Astra-Peregrine PR is purposely lacking any detail. They don't want anyone to know.

The last take away message or conclusion for me would be that Peregrine is paying. It sounds to me like there is a very large contingency that materializes if this works.

And if it works, Astra is not going to lose this opportunity by avoiding a few 10's of millions of dollars, most of which will be spent only after showing signal at phase I/Ib. Market size by 2018/19 is in the $20B-$30B range and will be transformative to any entity in the top 3 in sale of products.

I don't think Peregrine's pockets are being abused for this partnership.

Best,

MH